Hillsdale Investment Management Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $4 Million - $7.02 Million	-48,100 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$110.08 - $142.92 $121,088 - $157,212	-1,100 Reduced 2.24%	48,100 $5.7 Million
Q4 2021 Feb 07, 2022	BUY	$99.73 - $148.48 $4.08 Million - $6.07 Million	40,900 Added 492.77%	49,200 $6.78 Million
Q3 2021 Oct 21, 2021	BUY	$98.85 - $138.91 $820,455 - $1.15 Million	8,300 New	8,300 $1.15 Million

835K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.61B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.